US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US6268213B1
(en)
|
1992-06-03 |
2001-07-31 |
Richard Jude Samulski |
Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
US5869305A
(en)
|
1992-12-04 |
1999-02-09 |
The University Of Pittsburgh |
Recombinant viral vector system
|
JPH08506144A
(ja)
|
1993-02-05 |
1996-07-02 |
ラポート グループ オーストラリア リミティド |
スラグ脱泡複合材料
|
US20020173474A1
(en)
|
1993-02-12 |
2002-11-21 |
President And Fellows Of Harvard College |
Methods & materials involving dimerization-mediated regulation of biological events
|
US5830462A
(en)
|
1993-02-12 |
1998-11-03 |
President & Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
US6140120A
(en)
|
1993-02-12 |
2000-10-31 |
Board Of Trustees Of Leland Stanford Jr. University |
Regulated transcription of targeted genes and other biological events
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
EP1978095A1
(fr)
|
1993-02-12 |
2008-10-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Transcription régulée de gènes ciblés et autres évènements biologiques
|
US6972193B1
(en)
|
1993-02-12 |
2005-12-06 |
Board Of Trustees Of Leland Stanford Junior University |
Regulated transcription of targeted genes and other biological events
|
US5869337A
(en)
|
1993-02-12 |
1999-02-09 |
President And Fellows Of Harvard College |
Regulated transcription of targeted genes and other biological events
|
US6150137A
(en)
|
1994-05-27 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Immunosuppressant target proteins
|
US6492106B1
(en)
|
1994-06-27 |
2002-12-10 |
The Johns Hopkins University |
Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
|
US6476200B1
(en)
|
1994-06-27 |
2002-11-05 |
The Johns Hopkins University |
Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
US6150527A
(en)
|
1994-08-18 |
2000-11-21 |
Ariad Pharmaceuticals, Inc. |
Synthetic multimerizing agents
|
ATE299145T1
(de)
|
1994-08-18 |
2005-07-15 |
Ariad Gene Therapeutics Inc |
Neues multimerisierendes reagenz
|
US6133456A
(en)
|
1994-08-18 |
2000-10-17 |
Ariad Gene Therapeutics, Inc. |
Synthetic multimerizing agents
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
AU719001B2
(en)
|
1994-12-29 |
2000-05-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
US6326166B1
(en)
|
1995-12-29 |
2001-12-04 |
Massachusetts Institute Of Technology |
Chimeric DNA-binding proteins
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
US6187757B1
(en)
|
1995-06-07 |
2001-02-13 |
Ariad Pharmaceuticals, Inc. |
Regulation of biological events using novel compounds
|
US5741683A
(en)
|
1995-06-07 |
1998-04-21 |
The Research Foundation Of State University Of New York |
In vitro packaging of adeno-associated virus DNA
|
CA2219080A1
(fr)
|
1995-06-07 |
1996-12-27 |
Ariad Gene Therapeutics, Inc. |
Regulation d'evenements biologiques fondee sur la rapamycine
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
AU731826B2
(en)
|
1996-02-28 |
2001-04-05 |
Ariad Pharmaceuticals, Inc. |
Synthetic Multimerizing Agents
|
US6723531B2
(en)
|
1996-04-05 |
2004-04-20 |
The Salk Institute For Biological Studies |
Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
US6258823B1
(en)
|
1996-07-12 |
2001-07-10 |
Ariad Pharmaceuticals, Inc. |
Materials and method for treating or preventing pathogenic fungal infection
|
ES2224375T3
(es)
|
1997-04-14 |
2005-03-01 |
Cell Genesys, Inc. |
Metodos para aumentar la eficacia del producto de aav recombinante.
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
EP1017829A2
(fr)
|
1997-08-26 |
2000-07-12 |
Ariad Gene Therapeutics, Inc. |
Proteines de fusion a domaine de dimerisation, de trimerisation ou de tetramerisation, et a domaine additionnel d'activation de transcription heterologue, d'inhibition de transcription, de liaison d'adn ou de liaison de ligand
|
US6479653B1
(en)
|
1997-08-26 |
2002-11-12 |
Ariad Gene Therapeutics, Inc. |
Compositions and method for regulation of transcription
|
EP1003886A1
(fr)
|
1997-08-27 |
2000-05-31 |
Ariad Gene Therapeutics, Inc. |
Activateurs transcriptionnels chimeres, compositions et applications afferentes
|
JP2002508971A
(ja)
|
1998-01-15 |
2002-03-26 |
アリアド・ジーン・セラピューティクス・インコーポレーテッド |
多量体キメラ蛋白質を使用する生物学的イベントの調節
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
EP1053241A1
(fr)
|
1998-02-13 |
2000-11-22 |
President And Fellows Of Harvard College |
Agents de dimerisation, production et utilisation
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
EP1080218A1
(fr)
|
1998-05-27 |
2001-03-07 |
University of Florida |
Procede de preparation de compositions de virus adeno-associes de recombinaison a l'aide d'un gradient d'iodixananol
|
US6258603B1
(en)
|
1998-06-17 |
2001-07-10 |
Rohm And Haas Company |
Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
|
US7109317B1
(en)
|
1998-11-06 |
2006-09-19 |
President And Fellows Of Harvard College |
FK506-based regulation of biological events
|
JP2002538770A
(ja)
|
1998-11-10 |
2002-11-19 |
ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
ウイルスベクターとその製造及び投与の方法
|
ATE403715T1
(de)
|
1999-08-09 |
2008-08-15 |
Targeted Genetics Corp |
Erhöhung der expression einer einzelsträngigen, heterologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen
|
WO2001014387A1
(fr)
|
1999-08-24 |
2001-03-01 |
Ariad Gene Therapeutics, Inc. |
Analogues d'epirapamycine-28
|
US7067526B1
(en)
|
1999-08-24 |
2006-06-27 |
Ariad Gene Therapeutics, Inc. |
28-epirapalogs
|
US6780639B1
(en)
|
1999-08-24 |
2004-08-24 |
Universite Libre De Bruxelles |
Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization
|
JP3961737B2
(ja)
|
2000-02-29 |
2007-08-22 |
株式会社小糸製作所 |
車両用灯具およびその製造方法
|
CA2404253C
(fr)
|
2000-03-22 |
2014-05-13 |
Rohm And Haas Company |
Nouveau systeme d'expression genetique inducible fonde sur le le recepteur a l'ecdysone
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
AU6814901A
(en)
|
2000-06-01 |
2001-12-11 |
Univ North Carolina |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
US9493540B2
(en)
|
2001-02-20 |
2016-11-15 |
Intrexon Corporation |
Ecdysone receptor/invertebrate retinoid X receptor-based inducible gene expression system
|
JP4955905B2
(ja)
|
2001-02-20 |
2012-06-20 |
イントレキソン コーポレーション |
キメラレチノイドx受容体および新規エクジソン受容体−ベースの誘導性遺伝子発現システムにおけるそれらの使用
|
US9249207B2
(en)
|
2001-02-20 |
2016-02-02 |
Intrexon Corporation |
Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
|
US8715959B2
(en)
|
2001-02-20 |
2014-05-06 |
Intrexon Corporation |
Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
DK1310571T3
(da)
|
2001-11-13 |
2006-06-19 |
Univ Pennsylvania |
Fremgangsmåde til identifikation af ukendte adeno-associerede virussekvenser (AAV-sekvenser) og et kit til fremgangsmåden
|
EP1453547B1
(fr)
|
2001-12-17 |
2016-09-21 |
The Trustees Of The University Of Pennsylvania |
Sequences du serotype 8 du virus associe a l'adenovirus (aav), vecteurs les contenant et utilisations correspondantes
|
WO2003104413A2
(fr)
|
2002-06-05 |
2003-12-18 |
University Of Florida |
Production de virions de virus adeno-associe (aav) recombinants pseudo-types
|
GB2398783A
(en)
|
2003-02-26 |
2004-09-01 |
Antonio Lanzavecchia |
A method for producing immortalised human B memory lymphocytes
|
US8005620B2
(en)
|
2003-08-01 |
2011-08-23 |
Dna Twopointo Inc. |
Systems and methods for biopolymer engineering
|
EP2434420A3
(fr)
|
2003-08-01 |
2012-07-25 |
Dna Twopointo Inc. |
Systèmes et procédés d'ingénierie de biopolymère
|
ES2411479T3
(es)
|
2003-09-30 |
2013-07-05 |
The Trustees Of The University Of Pennsylvania |
Clados de virus adeno-asociados (AAV), secuencias, vectores que los contienen, y usos de los mismos
|
US20060246079A1
(en)
|
2003-11-14 |
2006-11-02 |
Morrow Phillip R |
Neutralizing human antibodies to anthrax toxin
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
EP3085389A1
(fr)
|
2005-04-07 |
2016-10-26 |
The Trustees Of The University Of Pennsylvania |
Procédé d'augmentation de la fonction d'un vecteur aav
|
EP1777906A1
(fr)
|
2005-06-09 |
2007-04-25 |
Matsushita Electric Industrial Co., Ltd. |
Appareil de compensation d erreur d amplitude et appareil de compensation d erreur d orthogonalité
|
US8877187B2
(en)
|
2005-07-25 |
2014-11-04 |
Avianax, Llc |
Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
|
EP2007795B1
(fr)
|
2006-03-30 |
2016-11-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Protéines de capsides aav
|
CN101528916B
(zh)
|
2006-04-28 |
2013-09-04 |
宾夕法尼亚大学托管会 |
规模可调的aav生产方法
|
US8603950B2
(en)
|
2007-02-20 |
2013-12-10 |
Anaptysbio, Inc. |
Methods of generating libraries and uses thereof
|
JP5346820B2
(ja)
|
2007-03-13 |
2013-11-20 |
エイチユーエムエイビーエス・リミテッド・ライアビリティ・カンパニー |
H5n1亜型a型インフルエンザウィルスに対する抗体
|
WO2008124934A1
(fr)
|
2007-04-17 |
2008-10-23 |
National Research Council Of Canada |
Constructions destinees a amplifier l'expression genetique dans un muscle
|
WO2008156763A2
(fr)
|
2007-06-15 |
2008-12-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anticorps monoclonaux neutralisants humains dirigés contre le virus de la grippe a h5n1
|
US7863425B2
(en)
|
2007-09-26 |
2011-01-04 |
Cornell University |
Compositions and methods for inhibiting Yersinia pestis infection
|
WO2009064805A1
(fr)
|
2007-11-12 |
2009-05-22 |
Spaltudaq Corporation |
Compositions et procédés pour traiter et diagnostiquer la grippe
|
EP3333187B1
(fr)
|
2007-12-06 |
2022-06-22 |
Dana-Farber Cancer Institute, Inc. |
Anticorps dirigés contre le virus de la grippe et leurs procédés d'utilisation
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
EP2296700A2
(fr)
|
2008-06-03 |
2011-03-23 |
Vaxin, Inc. |
Administration intranasale de ligands liant un récepteur ou de gènes codant pour lesdits ligands dans le cadre d'un schéma thérapeutique visant à atténuer les infections provoquées par des agents pathogènes respiratoires
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
JP5607620B2
(ja)
|
2008-07-25 |
2014-10-15 |
インスティテュート・フォー・リサーチ・イン・バイオメディシン |
抗a型インフルエンザウイルス中和抗体およびその使用
|
GB0813784D0
(en)
|
2008-07-28 |
2008-09-03 |
Ct Integrated Photonics Ltd |
Optical intergration system
|
NZ596032A
(en)
|
2009-05-11 |
2013-09-27 |
Crucell Holland Bv |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
WO2010138263A2
(fr)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Nouveaux virus adéno-associés (aav) et leurs utilisations
|
IT1395961B1
(it)
|
2009-06-01 |
2012-11-02 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
|
RU2560420C2
(ru)
|
2009-06-25 |
2015-08-20 |
МЕДИММЬЮН, ЭлЭлСи |
Варианты гемагглютининов вируса свиного гриппа
|
US8598331B2
(en)
|
2009-09-28 |
2013-12-03 |
The University Of British Columbia |
CLDN5 mini-promoters
|
US8101045B2
(en)
|
2010-01-05 |
2012-01-24 |
Nalco Company |
Modifying agent for yankee coatings
|
JP2013524218A
(ja)
|
2010-03-30 |
2013-06-17 |
バテル メモリアル インスティチュート |
軟膜セパレータフロートシステムおよび方法
|
US8927514B2
(en)
|
2010-04-30 |
2015-01-06 |
City Of Hope |
Recombinant adeno-associated vectors for targeted treatment
|
WO2012115980A1
(fr)
|
2011-02-22 |
2012-08-30 |
California Institute Of Technology |
Fourniture de protéines au moyen de vecteurs de virus adéno-associés (aav)
|
US20140031418A1
(en)
|
2011-04-20 |
2014-01-30 |
The Trustees Of The University Of Pennsylvania |
Regimens and Compositions for AAV-Mediated Passive Immunization of Airborne Pathogens
|
US20140127749A1
(en)
|
2011-04-21 |
2014-05-08 |
Arizona Borad Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizo |
Methods of protein production and compositions thereof
|
ES2608321T3
(es)
|
2011-07-14 |
2017-04-07 |
Janssen Vaccines & Prevention B.V. |
Moléculas de unión humanas capaces de neutralizar virus de la gripe A del grupo filogenético 1 y del grupo filogenético 2 y virus de la gripe B
|
CN103842601A
(zh)
|
2011-09-29 |
2014-06-04 |
艾利丹尼森公司 |
增加营销机会的防盗安全装置
|
WO2013114885A1
(fr)
|
2012-01-31 |
2013-08-08 |
Osaka University |
Anticorps monoclonaux humains protecteurs à large spectre contre le virus de la grippe b et méthodes d'utilisation correspondantes
|
CA2865594C
(fr)
|
2012-03-08 |
2021-07-27 |
Crucell Holland B.V. |
Molecules de liaison humaines aptes a se lier a des virus de la grippe b et de neutraliser des virus de la grippe b, et leurs utilisations
|
WO2013155222A2
(fr)
|
2012-04-10 |
2013-10-17 |
The Regents Of The University Of California |
Séquences activatrices spécifiques au cerveau pour thérapie cellulaire
|
US9218477B2
(en)
|
2012-04-13 |
2015-12-22 |
Lewis Innovative Technologies |
Electronic physical unclonable functions
|
EP3711771A1
(fr)
|
2012-08-01 |
2020-09-23 |
Ikaika Therapeutics, LLC |
Atténuation de lésions tissulaires et de la fibrose par l'intermédiaire de la protéine de liaison bêta (ltbp4) d'un facteur de croissance de transformation latente
|
AU2014236508A1
(en)
|
2013-03-14 |
2015-09-17 |
Contrafect Corporation |
Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
|
WO2015012924A2
(fr)
|
2013-04-29 |
2015-01-29 |
The Trustees Of The University Of Pennsylvania |
Cassettes d'expression préférentielle pour tissus modifiées par un codon, vecteurs les contenant, et utilisation
|
US9647491B2
(en)
|
2013-07-08 |
2017-05-09 |
Eaton Corporation |
UPS systems and methods using variable configuration
|
WO2015127136A2
(fr)
|
2014-02-19 |
2015-08-27 |
Jody Berry |
Anticorps monoclonaux anti-ebola
|
CA2946392A1
(fr)
|
2014-04-25 |
2015-10-29 |
James M. Wilson |
Variants de ldlr et leur utilisation dans des compositions permettant de reduire les taux de cholesterol
|
WO2015164723A1
(fr)
|
2014-04-25 |
2015-10-29 |
The Trustees Of The University Of Pennsylvania |
Procédés et compositions pour le traitement du cancer du sein métastatique et d'autres cancers dans le cerveau
|
MX365658B
(es)
|
2014-05-13 |
2019-06-10 |
Univ Pennsylvania |
Composiciones que comprenden virus adenoasociado (aav) que expresa constructos de anticuerpos duales y sus usos.
|
BR112017005892A2
(pt)
|
2014-09-24 |
2017-12-12 |
Hope City |
variantes de vetor de vírus adeno-associado para edição de genoma de alta eficácia e métodos da mesma
|
SG10201902924RA
(en)
|
2014-10-03 |
2019-05-30 |
Massachusetts Inst Technology |
Antibodies that bind ebola glycoprotein and uses thereof
|
JP6772157B2
(ja)
|
2015-02-05 |
2020-10-21 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. |
インフルエンザヘマグルチニンに対する結合分子及びその使用
|
EA201792500A1
(ru)
|
2015-05-13 |
2018-04-30 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Aav-опосредованная экспрессия антител против гриппа и способы их использования
|
WO2017040528A1
(fr)
|
2015-08-31 |
2017-03-09 |
The Trustees Of The University Of Pennsylvania |
Vecteur chimérique aav anti-vegf pour le traitement de cancers chez les canines
|
EP3387117B1
(fr)
|
2015-12-11 |
2022-11-23 |
The Trustees Of The University Of Pennsylvania |
Procédé de purification évolutif d'aav8
|
WO2017160360A2
(fr)
|
2015-12-11 |
2017-09-21 |
The Trustees Of The University Of Pennsylvania |
Méthode de purification évolutive pour virus adéno-associé 9 (aav9)
|
WO2017100674A1
(fr)
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Procédé de purification évolutif pour virus adéno-associé (aav) 1
|
US11028372B2
(en)
|
2015-12-11 |
2021-06-08 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAVRH10
|
US20190002915A1
(en)
|
2015-12-14 |
2019-01-03 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for regulatable antibody expression
|
WO2017106326A1
(fr)
|
2015-12-14 |
2017-06-22 |
The Trustees Of The University Of Pennsylvania |
Constructions d'anticorps anti-pcsk9 de virus adéno-associé et leurs utilisations
|
US20190240328A1
(en)
|
2016-09-24 |
2019-08-08 |
The Trustees Of The University Of Pennsylvania |
Novel humanized anti-ebola antibodies useful in preventing ebola infections
|
SG10201913833PA
(en)
|
2017-02-28 |
2020-03-30 |
Univ Pennsylvania |
Influenza vaccines based on aav vectors
|